Michael Barbella, Managing Editor06.28.23
OrthoPediatrics Corp. has completed the first clinical case using the new GIRO Growth Modulation System and commenced a limited market release of the product.
The GIRO tether device is indicated for pediatric patients to aid in the correction of angular deformities of long bones and limb length discrepancy. Two configurations of the system are available, the GIRO Screw configuration for deformities in the femur and tibia, humerus, radius and ulna or ankle and the GIRO Post configuration for limb length discrepancy of the femur and tibia. The GIRO Growth Modulation system represents the first new Pega Medical system to receive FDA clearance and be launched under OrthoPediatrics and the company’s 50th system for pediatric orthopedic care.
The first case was completed last week to treat a patient’s bilateral femoral anteversion without additional osteotomy, making this a less invasive procedure with shorter recovery time and less risk of complications. The low profile implants make GIRO a versatile tethering system and an attractive option for treating patients’ angular deformities and limb length discrepancies moving forward.
“The first clinical case with the GIRO Growth Modulation system represents a milestone for our business as we continue to leverage the technology and expertise of our colleagues at OrthoPediatrics Canada. This system provides our pediatric orthopedic surgeon partners with a new option to treat their patients, we are excited to see this technology improve the care of kids,” said Joe Hauser, president of Trauma and Deformity Correction at OrthoPediatrics.
Founded in 2006, OrthoPediatrics Corp. is an orthopedic company that has developed a comprehensive product offering for the pediatric orthopedic market. OrthoPediatrics currently markets 50 surgical systems that serve three of the largest categories within the pediatric orthopedic market spanning trauma and deformity, scoliosis, and sports medicine/other procedures. The company distributes its products in the United States and more than 70 countries internationally.
The GIRO tether device is indicated for pediatric patients to aid in the correction of angular deformities of long bones and limb length discrepancy. Two configurations of the system are available, the GIRO Screw configuration for deformities in the femur and tibia, humerus, radius and ulna or ankle and the GIRO Post configuration for limb length discrepancy of the femur and tibia. The GIRO Growth Modulation system represents the first new Pega Medical system to receive FDA clearance and be launched under OrthoPediatrics and the company’s 50th system for pediatric orthopedic care.
The first case was completed last week to treat a patient’s bilateral femoral anteversion without additional osteotomy, making this a less invasive procedure with shorter recovery time and less risk of complications. The low profile implants make GIRO a versatile tethering system and an attractive option for treating patients’ angular deformities and limb length discrepancies moving forward.
“The first clinical case with the GIRO Growth Modulation system represents a milestone for our business as we continue to leverage the technology and expertise of our colleagues at OrthoPediatrics Canada. This system provides our pediatric orthopedic surgeon partners with a new option to treat their patients, we are excited to see this technology improve the care of kids,” said Joe Hauser, president of Trauma and Deformity Correction at OrthoPediatrics.
Founded in 2006, OrthoPediatrics Corp. is an orthopedic company that has developed a comprehensive product offering for the pediatric orthopedic market. OrthoPediatrics currently markets 50 surgical systems that serve three of the largest categories within the pediatric orthopedic market spanning trauma and deformity, scoliosis, and sports medicine/other procedures. The company distributes its products in the United States and more than 70 countries internationally.